Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F V Gleeson

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The British Journal of Surgery|February 14, 2012
Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinomaR S Gillies, M R Middleton, C Han, et al.
Clinical Radiology|July 26, 2020
Multi-observer concordance and accuracy of the British Thoracic Society scale and other visual assessment qualitative criteria for solid pulmonary nodule assessment using FDG PET-CTK Fatania, P J Brown, C Xie, et al.
Clinical Radiology|June 29, 2020
Chest CT screening for COVID-19 in elective and emergency surgical patients: experience from a UK tertiary centreM R Chetan, M T Tsakok, R Shaw, et al.
Thorax|August 1, 2014
Role of CT in assessing pleural malignancy prior to thoracoscopyR J Hallifax, M Haris, J P Corcoran, et al.
European Radiology|May 8, 2012
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancerR S Gillies, M R Middleton, C Blesing, et al.
European Journal of Radiology|March 25, 2018
Pulmonary nodules: Assessing the imaging biomarkers of malignancy in a "coffee-break"A Talwar, J M Y Willaime, L C Pickup, et al.
The British Journal of Surgery|January 18, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
The British Journal of Surgery|May 19, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
British Journal of Cancer|September 29, 2005
The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western populationR O Illing, J E Kennedy, F Wu, et al.
The Medical Journal of Australia|April 16, 1998
Two contiguous outbreaks of dengue type 2 in north QueenslandJ N Hanna, S A Ritchie, A D Merritt, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The British Journal of Surgery|February 14, 2012
Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinomaR S Gillies, M R Middleton, C Han, et al.
Clinical Radiology|July 26, 2020
Multi-observer concordance and accuracy of the British Thoracic Society scale and other visual assessment qualitative criteria for solid pulmonary nodule assessment using FDG PET-CTK Fatania, P J Brown, C Xie, et al.
Clinical Radiology|June 29, 2020
Chest CT screening for COVID-19 in elective and emergency surgical patients: experience from a UK tertiary centreM R Chetan, M T Tsakok, R Shaw, et al.
Thorax|August 1, 2014
Role of CT in assessing pleural malignancy prior to thoracoscopyR J Hallifax, M Haris, J P Corcoran, et al.
European Radiology|May 8, 2012
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancerR S Gillies, M R Middleton, C Blesing, et al.
European Journal of Radiology|March 25, 2018
Pulmonary nodules: Assessing the imaging biomarkers of malignancy in a "coffee-break"A Talwar, J M Y Willaime, L C Pickup, et al.
The British Journal of Surgery|January 18, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
The British Journal of Surgery|May 19, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
British Journal of Cancer|September 29, 2005
The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western populationR O Illing, J E Kennedy, F Wu, et al.
The Medical Journal of Australia|April 16, 1998
Two contiguous outbreaks of dengue type 2 in north QueenslandJ N Hanna, S A Ritchie, A D Merritt, et al.
Pageof 10